| Date | Title | Description |
| 08.10.2024 | Invitation to media and analyst briefing for BioGaia Q3 2024 report | Invitation to media and analyst briefing for BioGaia Q3 2024 report
Tue, Oct 08, 2024 11:30 CET Report this content
BioGaia's (NASDAQ: BIOG) financial report for the third quarter of 2024 will be published at approximately 8:00 AM CEST on O... |
| 29.08.2024 | BioGaia's Share Sale: A Strategic Move in the Market | On August 27, 2024, BioGaia AB, a Swedish biotechnology company, made headlines with its announcement of a secondary placing of ordinary shares. This move is not just a financial transaction; it’s a strategic pivot in the corporate landscap... |
| 27.08.2024 | Proposed Secondary Placing of ordinary shares in BioGaia AB | Proposed Secondary Placing of ordinary shares in BioGaia AB
Tue, Aug 27, 2024 17:30 CET Report this content
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR ... |
| 27.08.2024 | Secondary Placing of ordinary shares in BioGaia AB | Secondary Placing of ordinary shares in BioGaia AB
Tue, Aug 27, 2024 22:00 CET Report this content
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, ... |
| 16.07.2024 | Invitation to media and analyst briefing for BioGaia Q2 2024 report | Invitation to media and analyst briefing for BioGaia Q2 2024 report
Tue, Jul 16, 2024 10:00 CET Report this content
BioGaia's (NASDAQ: BIOG) financial report for the second quarter of 2024 will be published at approximately 8:00 AM CEST on ... |
| 05.06.2024 | BioGaia AB establishes its own distribution in Australia and New Zealand | BioGaia AB establishes its own distribution in Australia and New Zealand
Wed, Jun 05, 2024 08:00 CET Report this content
BioGaia AB, a Swedish world-leading probiotics company, is establishing its own distribution in Australia and New Zeala... |
| 13.05.2024 | 80% of parents use processed pre-packaged baby foods during weaning which could be damaging to long-term baby gut health | Weaning Week 2023
HITCHIN, UNITED KINGDOM, May 13, 2024 /EINPresswire.com/ -- With such a high percentage of parents using pre-packaged baby foods, Weaning World, The Gut Stuff, BioGaia and Lucy Upton have teamed up to provide parents with ... |
| 26.04.2024 | Invitation to media and analyst briefing for BioGaia Q1 2024 report | Invitation to media and analyst briefing for BioGaia Q1 2024 report
Fri, Apr 26, 2024 10:30 CET Report this content
BioGaia's (NASDAQ: BIOG) financial report for the first quarter of 2024 will be published at approximately 8:00 AM CEST on M... |
| 31.01.2024 | Invitation to media and analyst briefing for BioGaia Q4 2023 report | Invitation to media and analyst briefing for BioGaia Q4 2023 report
Wed, Jan 31, 2024 10:15 CET Report this content
BioGaia's (NASDAQ: BIOG) financial report for the fourth quarter of 2023 will be published at approximately 8:00 AM CET on F... |
| 20.10.2023 | BioGaia AB: Interim report third quarter January – September 2023 | BioGaia AB: Interim report third quarter January – September 2023
Fri, Oct 20, 2023 08:00 CET Report this content
THIRD QUARTER 2023
Figures in parentheses refer to the corresponding period last year, unless otherwise specified. Net sales a... |
| 18.10.2023 | BioGaia AB’s Nomination Committee for the 2024 Annual General Meeting | BioGaia AB’s Nomination Committee for the 2024 Annual General Meeting
Wed, Oct 18, 2023 13:00 CET Report this content
BioGaia AB’s Nomination Committee for the Annual General Meeting 2024 has been appointed based on the ownership structure ... |
| 16.10.2023 | BioGaia’s results for the third quarter to exceed market expectations | BioGaia’s results for the third quarter to exceed market expectations
Mon, Oct 16, 2023 22:00 CET Report this content
(Figures in the brackets refer to the same period the previous year)
During the third quarter of 2023, BioGaia's sales hav... |
| 13.10.2023 | Invitation to media and analyst briefing for BioGaia Q3 2023 report | Invitation to media and analyst briefing for BioGaia Q3 2023 report
Fri, Oct 13, 2023 12:30 CET Report this content
BioGaia's (NASDAQ: BIOG) financial report for the third quarter of 2023 will be published at approximately 8:00 AM CEST on O... |
| 25.09.2023 | Theresa Agnew commences her role as CEO of BioGaia | Theresa Agnew commences her role as CEO of BioGaia
Mon, Sep 25, 2023 14:30 CET Report this content
BioGaia announces that Theresa Agnew begins her role today, 25 September 2023, as the Chief Executive Officer of BioGaia.
As previously commu... |
| 01.09.2023 | Introducing BioGaia Prodentis KIDS in Sweden | Introducing BioGaia Prodentis KIDS in Sweden
Fri, Sep 01, 2023 16:00 CET Report this content
BioGaia introduces Prodentis for kids, an apple-flavored lozenge with probiotics and xylitol for oral health, to complement the daily toothbrushing... |
| 07.08.2023 | BioGaia and University of Gothenburg reach an important milestone towards next-generation probiotics | BioGaia and University of Gothenburg reach an important milestone towards next-generation probiotics
Mon, Aug 07, 2023 11:00 CET Report this content
In a paper published in the journal Nature, a team of researchers from the University of Go... |
| 02.08.2023 | BioGaia appoints Theresa Agnew as new CEO | BioGaia appoints Theresa Agnew as new CEO
Wed, Aug 02, 2023 15:30 CET Report this content
Today BioGaia´s board of directors has appointed Theresa P. Agnew as the new chief executive officer.
Theresa Agnew is a global business leader with c... |
| 21.07.2023 | BioGaia AB: Interim Management Statement January – June 2023 | BioGaia AB: Interim Management Statement January – June 2023
Fri, Jul 21, 2023 08:00 CET Report this content
SECOND QUARTER 2023
Figures in parentheses refer to the corresponding period last year, unless otherwise specified. Net sales amoun... |
| 18.07.2023 | Invitation to media and analyst briefing for BioGaia Q2 2023 report | Invitation to media and analyst briefing for BioGaia Q2 2023 report
Tue, Jul 18, 2023 11:00 CET Report this content
BioGaia's (NASDAQ: BIOG) financial report for the second quarter of 2023 will be published at approximately 8:00 AM CEST on ... |
| 05.07.2023 | BioGaia’s probiotic Protectis increases SARS-CoV-2 antibody response in adults | BioGaia’s probiotic Protectis increases SARS-CoV-2 antibody response in adults
Wed, Jul 05, 2023 16:30 CET Report this content
A randomised, triple-blinded, placebo-controlled study with BioGaia’s probiotic Protectis was shown to increase S... |
| 26.06.2023 | BioGaia earns Gold Medal from EcoVadis for Sustainability Performance | BioGaia earns Gold Medal from EcoVadis for Sustainability Performance
Mon, Jun 26, 2023 09:30 CET Report this content
BioGaia has been awarded a gold medal recognizing its sustainability achievements by EcoVadis, one of the world's most tru... |
| 05.05.2023 | BioGaia AB: Interim Management Statement – January - March 2023 | BioGaia AB: Interim Management Statement – January - March 2023
Fri, May 05, 2023 08:00 CET Report this content
FIRST QUARTER 2023
Figures in parentheses refer to the corresponding period last year, unless otherwise specified. Net sales amo... |
| 05.05.2023 | Annual General Meeting of BioGaia | Annual General Meeting of BioGaia
Fri, May 05, 2023 19:00 CET Report this content
The Annual General Meeting of BioGaia AB (publ) on 5 May 2023 voted, among other things, to approve the following resolutions: adoption of the income statemen... |
| 28.04.2023 | Invitation to media and analyst briefing for BioGaia Q1 2023 report | Invitation to media and analyst briefing for BioGaia Q1 2023 report
Fri, Apr 28, 2023 13:00 CET Report this content
BioGaia's (NASDAQ: BIOG) financial report for the first quarter of 2023 will be published at approximately 8:00 AM CEST on M... |
| 27.04.2023 | BioGaia launches a probiotic food supplement for women before and during pregnancy | BioGaia launches a probiotic food supplement for women before and during pregnancy
Thu, Apr 27, 2023 19:05 CET Report this content
Prenatal Care is a probiotic food supplement that contains BioGaia's patented bacteria strain L. reuteri DSM ... |
| 26.04.2023 | BioGaia’s results for the first quarter to exceed market expectations | BioGaia’s results for the first quarter to exceed market expectations
Wed, Apr 26, 2023 19:00 CET Report this content
(Figures in the brackets refer to the same period the previous year)
During the first quarter of 2023, BioGaia's sales hav... |
| 03.04.2023 | Notice to attend the Annual General Meeting of BioGaia AB (publ) | Notice to attend the Annual General Meeting of BioGaia AB (publ)
Mon, Apr 03, 2023 15:59 CET Report this content
BioGaia AB (publ) will hold its Annual General Meeting at 4:00 p.m. on Friday, 5 May 2023, at Kapitel 8, Klara Strand, Klaraber... |
| 31.03.2023 | BioGaia launches probiotic skin ointment for infants and children | BioGaia launches probiotic skin ointment for infants and children
Fri, Mar 31, 2023 11:00 CET Report this content
For the first time in its over 30-year history, BioGaia is launching its own cosmetic probiotic product, Aldermis. Children’s ... |
| 27.03.2023 | BioGaia Annual and Sustainability Report 2022 published | BioGaia Annual and Sustainability Report 2022 published
Mon, Mar 27, 2023 11:00 CET Report this content
The BioGaia (NASDAQ: BIOG) Annual and Sustainability Report 2022, Remuneration Report 2022 and Corporate Governance Report 2022 in Swedi... |
| 03.02.2023 | BioGaia AB: Year-end report January – December 2022 | BioGaia AB: Year-end report January – December 2022
Fri, Feb 03, 2023 08:00 CET Report this content
FOURTH QUARTER 2022 Net sales amounted to SEK 274.3 million (206.2), an increase of SEK 68.1 million, or 33% (excluding foreign exchange eff... |
| 20.01.2023 | Invitation to media and analyst briefing for BioGaia Q4 and full year 2022 report | Invitation to media and analyst briefing for BioGaia Q4 and full year 2022 report
Fri, Jan 20, 2023 11:00 CET Report this content
BioGaia's (NASDAQ: BIOG) financial report for the fourth quarter and full year of 2022 will be published at ap... |
| 21.10.2022 | BioGaia AB: Interim report third quarter January – September 2022 | BioGaia AB: Interim report third quarter January – September 2022
Fri, Oct 21, 2022 08:00 CET Report this content
THIRD QUARTER 2022 Net sales amounted to SEK 257.7 million (173.8), an increase of SEK 83.9 million, or 48% (excluding foreign... |
| 29.08.2022 | MetaboGen and BioGaia open pilot plant for new bacterial strains | MetaboGen and BioGaia open pilot plant for new bacterial strains
Mon, Aug 29, 2022 15:30 CET Report this content
BioGaia is developing probiotic products and expanding its product portfolio with new bacterial strains, developed together wit... |
| 22.07.2022 | BioGaia AB Interim Management Statement - January – June 2022 | BioGaia AB Interim Management Statement - January – June 2022
Fri, Jul 22, 2022 08:00 CET Report this content SECOND QUARTER 2022 Net sales amounted to SEK 288.1 million (203.1), an increase of SEK 85.0 million, or 42% (excluding foreign ex... |
| 14.07.2022 | BioGaia’s result for second quarter to exceed market expectations | BioGaia’s result for second quarter to exceed market expectations
Thu, Jul 14, 2022 08:00 CET Report this content
(Figures in brackets refer to the same period the previous year)
BioGaia´s sales for the second quarter has been positively im... |
| 01.07.2022 | BioGaia launches probiotic product to support children’s respiratory health | BioGaia launches probiotic product to support children’s respiratory health
Fri, Jul 01, 2022 08:00 CET Report this content
The US is the first market to launch BioGaia Pharax, which aims to strengthen the immune system and support children... |
| 08.06.2022 | BioGaia signs exclusive agreement in South Korea for the baby gut health range | BioGaia signs exclusive agreement in South Korea for the baby gut health range
Wed, Jun 08, 2022 08:00 CET Report this content
BioGaia has extended its collaboration with Grace International, giving the company exclusive rights to market an... |
| 31.05.2022 | New number of shares and votes in BioGaia AB (publ) | New number of shares and votes in BioGaia AB (publ)
Tue, May 31, 2022 08:00 CET Report this content
The number of shares and votes in BioGaia has increased during May due to the share split resolved by BioGaia’s Annual General Meeting on 6 ... |
| 17.05.2022 | BioGaia starts its own distribution in Canada | BioGaia starts its own distribution in Canada
Tue, May 17, 2022 08:00 CET Report this content
Starting in 2023, BioGaia will be selling probiotics under its own management in Canada. Following the acquisition of Nutraceutics in the US at th... |
| 11.05.2022 | BioGaia® Osfortis® winner of the NutraIngredients Awards 2022 | BioGaia® Osfortis® winner of the NutraIngredients Awards 2022
Wed, May 11, 2022 09:00 CET Report this content
We are proud to announce that our probiotic for bone health, Osfortis, is the winner of the 2022 NutraIngredients Awards in the ca... |
| 06.05.2022 | BioGaia AB Interim Management Statement - January – March 2022 | BioGaia AB Interim Management Statement - January – March 2022
Fri, May 06, 2022 08:00 CET Report this content FIRST QUARTER 2022
Net sales amounted to SEK 283.9 million (202.0), an increase of SEK 81.9 million, or 41% (excluding foreign ex... |
| 06.05.2022 | Annual General Meeting of BioGaia | Annual General Meeting of BioGaia
Fri, May 06, 2022 12:00 CET Report this content
The Annual General Meeting of BioGaia AB (publ) on 6 May 2022 voted, among other things, to approve the following resolutions: adoption of the income statemen... |
| 06.05.2022 | Record date for share split in BioGaia AB (publ) determined as 19 May 2022 | Record date for share split in BioGaia AB (publ) determined as 19 May 2022
Fri, May 06, 2022 13:00 CET Report this content
At BioGaia’s Annual General Meeting held earlier today, on 6 May 2022, it was resolved on a share split of the compan... |
| 25.04.2022 | BioGaia’s result for first quarter to exceed market expectations | BioGaia’s result for first quarter to exceed market expectations
Mon, Apr 25, 2022 08:00 CET Report this content
(Figures in brackets refer to the same period the previous year)
BioGaia´s sales for the first quarter has been positively impa... |
| 05.04.2022 | Notice to attend the Annual General Meeting of BioGaia AB (publ) | Notice to attend the Annual General Meeting of BioGaia AB (publ)
Tue, Apr 05, 2022 14:00 CET Report this content
BioGaia AB (publ) will hold its Annual General Meeting on Friday, 6 May 2022. The meeting will be held through advance voting. ... |
| 28.03.2022 | BioGaia publishes annual report for 2021 | BioGaia publishes annual report for 2021
Mon, Mar 28, 2022 08:00 CET Report this content
Today, BioGaia AB (publ) publishes its Annual Report, Remuneration Report and Sustainability Report for the financial year 2021. In line with BioGaia’s... |
| 10.02.2022 | BioGaia Pharma announces First Patient Enrolled in Phase I Clinical Study Evaluating BGP014 in mild to moderate ulcerative colitis (AUCH-1). | BioGaia Pharma announces First Patient Enrolled in Phase I Clinical Study Evaluating BGP014 in mild to moderate ulcerative colitis (AUCH-1).
Thu, Feb 10, 2022 09:30 CET Report this content
BioGaia Pharma received formal approval from releva... |
| 04.02.2022 | BioGaia AB - Year-end Report 2021 | BioGaia AB - Year-end Report 2021
Fri, Feb 04, 2022 08:00 CET Report this content FOURTH QUARTER 2021
Net sales amounted to SEK 206.2 million (187.6), an increase of 10% (excluding foreign exchange effects, 11%).
Net sales in the Paediatric... |
| 03.02.2022 | BioGaia’s probiotic reduces inflammation in patients with diverticulitis | BioGaia’s probiotic reduces inflammation in patients with diverticulitis
Thu, Feb 03, 2022 08:00 CET Report this content
A randomized, double-blind, placebo-controlled study with BioGaia’s probiotic strain Limosilactobacillus reuteri ATCC P... |
| 26.01.2022 | BioGaia Pharma announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the treatment of opioid induced constipation (OIC-1) | BioGaia Pharma announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the treatment of opioid induced constipation (OIC-1) Wed, Jan 26, 2022 09:30 CET
BioGaia Pharma received formal approval from relevant authori... |
| 30.12.2021 | BioGaia acquires its US distributor - strengthening its market position in the US | BioGaia acquires its US distributor - strengthening its market position in the US Thu, Dec 30, 2021 17:40 CET
BioGaia AB (publ) has, through its US subsidiary BioGaia Biologics Inc, signed an agreement to acquire all shares in Nutraceutics ... |
| 30.12.2021 | BioGaia acquires its US distributor - strengthening its market position in the US | BioGaia AB (publ) has, through its US subsidiary BioGaia Biologics Inc, signed an agreement to acquire all shares in Nutraceutics Corporation ("Nutraceutics"). Nutraceutics holds all shares in Everidis Inc ("Everidis"), ... |
| 09.11.2021 | BioGaia AB’s Nomination Committee for the 2022 Annual General Meeting | BioGaia AB’s Nomination Committee for the 2022 Annual General Meeting Tue, Nov 09, 2021 15:30 CET
BioGaia AB’s Nomination Committee for the Annual General Meeting 2022 has been appointed based on the ownership structure as of June 30, 2021.... |
| 21.10.2021 | BioGaia AB Interim Management Statement - January – September 2021 | BioGaia AB Interim Management Statement - January – September 2021 Thu, Oct 21, 2021 08:00 CET Third quarter 2021 Net sales amounted to SEK 173.8 million (132.0), an increase of 32% (excluding foreign exchange effects, 35%) Net sales in the... |
| 13.10.2021 | BioGaia’s profit for third quarter to exceed market expectations | BioGaia’s profit for third quarter to exceed market expectations Wed, Oct 13, 2021 21:00 CET
(Figures in brackets refer to the year-earlier period)
In the latter part of the third quarter of 2021, BioGaia was requested by certain customers ... |
| 20.09.2021 | BioGaia starts its own distribution in the UK | BioGaia starts its own distribution in the UK Mon, Sep 20, 2021 08:00 CET
Beginning in November 2021, BioGaia will be selling its probiotic products under its own management in the UK market. The decision is part of the company’s overall st... |
| 10.09.2021 | BioGaia Pharma secures approval for two clinical trials for its pharmaceutical candidates | BioGaia Pharma secures approval for two clinical trials for its pharmaceutical candidates Fri, Sep 10, 2021 10:00 CET
BioGaia Pharma has received formal approval from relevant authorities to proceed with both of its planned clinical trials.... |
| 10.09.2021 | BioGaia : Pharma secures approval for two clinical trials for its pharmaceutical candidates | BioGaia Pharma has received formal approval from relevant authorities to proceed with both of its planned clinical trials. The trials are the next phase in the development of BioGaia Pharma's two pharmaceutical product candidates. The biolo... |
| 08.09.2021 | BioGaia research wins first prize at LAB Symposium | BioGaia research wins first prize at LAB Symposium Wed, Sep 08, 2021 15:00 CET
The prestigious International Symposium on Lactic Acid Bacteria was held between 23–25 August and gathered more than 300 participants. Together with researchers ... |
| 12.08.2021 | BioGaia : Interim Report 1 January – 30 June 2021 | Interim report
JANUARY - JUNE 2021
BioGaia AB (Publ) Interim Report, January - June 2021
Q2
2021
SECOND QUARTER 2021 FIRST HALF 2021
Net sales amounted to SEK 203.1 million (244.7), a decrease of 17% (excluding foreign exchange effects, -8%... |
| 12.08.2021 | BioGaia Interim report January - June 2021 | BioGaia Interim report January - June 2021 Thu, Aug 12, 2021 08:00 CET Second quarter 2021
Net sales amounted to SEK 203.1 million (244.7), a decrease of 17% (excluding foreign exchange effects, -8%). The change in sales was affected by hig... |
| 20.05.2021 | BIOGAIA AB (PUBL)
BioGaia : opens up new subsidiary in Finland - Takes over local distribution with BioGaia brand | Starting in Q2 2021, BioGaia's products will be sold under the BioGaia brand in Finland, due to the termination of the former distribution agreement with the Finnish company Verman. The takeover of the distribution is a strategic step for B... |
| 20.05.2021 | BIOGAIA AB (PUBL)
BioGaia : opens up new subsidiary in Finland – Takes over local distribution with BioGaia brand | Starting in Q2 2021, BioGaia's products will be sold under the BioGaia brand in Finland, due to the termination of the former distribution agreement with the Finnish company Verman. The takeover of the distribution is a strategic step for B... |
| 20.05.2021 | BioGaia opens up new subsidiary in Finland – Takes over local distribution with BioGaia brand | BioGaia opens up new subsidiary in Finland – Takes over local distribution with BioGaia brand Thu, May 20, 2021 15:01 CET
Starting in Q3 2021, BioGaia’s products will be sold under the BioGaia brand in Finland, due to the termination of the... |
| 06.05.2021 | BIOGAIA AB (PUBL)
BioGaia : Interim Management Statement 1 January – 31 March 2021 | Interim Management Statement
JANUARY - MARCH 2021
Q1
2021
FIRST QUARTER 2021
Net sales amounted to SEK 202.0 million (182.8), an increase of 10% (excluding foreign exchange effects, 21%). Product sales, net sales excluding royalty revenues,... |
| 31.03.2021 | BioGaia publishes annual report for 2020 | BioGaia publishes annual report for 2020 Wed, Mar 31, 2021 11:00 CET
Today, BioGaia AB (publ) publishes its Annual Report, Remuneration report and Sustainability report for the financial year 2020. In line with BioGaia’s sustainability stra... |
| 07.09.2015 | Orphan drug developer Infant Bacterial Therapeutics gets $4.1 million | While there is no true cure, some research is underway to identify children at risk for necrotising enterocolitis and use preventative measures to counter the disease.
This latest round of financing brings BioGaia’s total investment in Infa... |
| - | Orphan drug developer Infant Bacterial Therapeutics gets $4.1 million | Sweden-based BioGaia is pumping another $4.1 million into its subsidiary Infant Bacterial Therapeutics, which is developing an orphan drug focused on an intestinal disease specific to premature babies.
Clinical trials will begin sometime in... |
